Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2
The late endo-/lysosomal P-type ATPase ATP13A2 (PARK9) is implicated in Parkinson’s disease (PD) and Kufor-Rakeb syndrome, early-onset atypical Parkinsonism. ATP13A2 interacts at the N-terminus with the signaling lipids phosphatidic acid (PA) and phosphatidylinositol (3,5) bisphosphate (PI(3,5)P2),...
Saved in:
Main Authors: | Shaun Martin, Sarah van Veen, Tine Holemans, Seyma Demirsoy, Chris van den Haute, Veerle Baekelandt, Patrizia Agostinis, Jan Eggermont, Peter Vangheluwe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2016/9531917 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ATP-binding cassette transporters and drug resistance in cutaneous leishmaniasis
by: Marina B.R. de Santana, et al.
Published: (2025-02-01) -
Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease
by: Géraldine Gelders, et al.
Published: (2018-01-01) -
S-DCNN: prediction of ATP binding residues by deep convolutional neural network based on SMOTE
by: Sixi Hao, et al.
Published: (2025-01-01) -
ATP-Binding Cassette Transporters Modulate Both Coelenterazine- and D-Luciferin-Based Bioluminescence Imaging
by: Ruimin Huang, et al.
Published: (2011-05-01) -
Molecular determinants of Neu5Ac binding to a tripartite ATP independent periplasmic (TRAP) transporter
by: Parveen Goyal, et al.
Published: (2025-02-01)